Eisai Pharmaceuticals India

Eisai Pharmaceuticals India Pvt. Ltd. (Eisai India) was incorporated in October 2004, with registered office at Mumbai. Eisai Co.,Ltd was the first Japanese company to have a 100% subsidiary in Indian pharmaceutical market. Eisai India product portfolio includes prescription medicines in several therapeutic areas such as central nervous system disorders, metastatic breast cancer, benign prostrate hyperplasia , muscle spasm, vertigo, gastrointestinal disorders, diabetes and peripheral neuropathy. Eisai India has a dedicated team of well-trained 165 field force across the country under various specialties. We continuously work with Medical Doctors and the Healthcare professionals in India to ensure that they have updated information on our products so that they can prescribe the best products for the health care needs of their patients. Eisai India’s integrated Manufacturing and Research complex at Visakhapatnam (Vizag), Andhra Pradesh stimulates knowledge creation between teams – from those who create products through research, to those who produce - by bringing them together on one site with all the necessary support functions. Eisai India’s Vizag facility manufactures Drug Substances (Active Pharmaceutical Ingredients-APIs), Drug Products (Oral solid dosage forms-Tablets) and carries out Developmental Research of Active Pharmaceutical Ingredients (APIs).This facility is registered as a pharmaceutical manufacturer at regulatory agencies viz USFDA, PMDA, MHRA and WHO. Research labs at Vizag facility are recognized by the Department of scientific and industrial research (DSIR). Facility also received the Certification of ISO 14001:2004 for Environment management system (EMS) from TUV SUD.

show less